Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease

BackgroundAlzheimer's disease (AD) accompanied by psychotic symptoms (PS) has a poor prognosis and may be associated with imbalances in key neural proteins such as alpha-synuclein (AS).AimThe aim of the study was to evaluate the diagnostic validity of AS levels in the cerebrospinal fluid (CSF)...

Full description

Bibliographic Details
Main Authors: Sonia Monge-García, María-Salud García-Ayllón, José Sánchez-Payá, Ruth Gasparini-Berenguer, María-Ángeles Cortés-Gómez, Javier Sáez-Valero, José-Antonio Monge-Argilés
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Neurology
Subjects:
psychosis
Alzheimer
alpha-synuclein
CSF
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1124145/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1124145/full

Similar Items